The first generation of candidate HIV-1 vaccines can induce antibodies able to neutralize primary isolates in assays with extended incubation phases

By Donners H.   Vermoesen T.   Willems B.   Davis D.   van der Groen G.  

Vaccine, Vol. 22, Iss. 1, 2003-12 ,pp. : 104-111

Elsevier

Access to resources Recommend Favorite

Passive immunization with human neutralizing monoclonal antibodies: correlates of protective immunity against HIV

By Xu W.   Hofmann-Lehmann R.   McClure H.M.   Ruprecht R.M.  

Vaccine, Vol. 20, Iss. 15, 2002-05 ,pp. : 1956-1960

Elsevier

Access to resources Recommend Favorite

Development of peptide vaccines inducing production of neutralizing antibodies against HIV-1 viruses in HLA-DQ6 mice

By Takahashi A.   Ogasawara K.   Matsuki N.   Fujinaga K.   Nakaya T.   Ikuta K.   Auwanit W.   Honda M.   Fukui Y.   Sasazuki T.   Iwabuchi K.   Onoe K.  

Vaccine, Vol. 16, Iss. 16, 1998-10 ,pp. : 1537-1543

Elsevier

Access to resources Recommend Favorite

Neisseria gonorrhoeae IgA1 proteases share epitopes recognized by neutralizing antibodies

By Lomholt H.   Lind I.   Kilian M.  

Vaccine, Vol. 13, Iss. 13, 1995-01 ,pp. : 1213-1219

Elsevier

Access to resources Recommend Favorite

Vaccine-induced antibodies to the native, oligomeric envelope glycoproteins of primary HIV-1 isolates

By Lee S.A.   Orque R.   Escarpe P.A.   Peterson M.L.   Good J.W.   Zaharias E.M.   Berman P.W.   Sheppard H.W.   Shibata R.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 563-576

Elsevier

Access to resources Recommend Favorite